Page last updated: 2024-08-25

bromopyruvate and lonidamine

bromopyruvate has been researched along with lonidamine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corazzi, L; Davidescu, M; Macchioni, L; Roberti, R1
Cromarty, AD; Joubert, AM; van Tonder, A1
Castigli, E; Corazzi, L; Corcelli, A; Cristina Marchetti, M; Davidescu, M; Macchioni, L; Migliorati, G; Roberti, R; Scaramozzino, G; Vitale, R1
Hu, X; Liu, H; Pan, T; Tan, R; Tan, W; Wang, S; Wang, Y; Yu, H; Zhong, Z1

Reviews

1 review(s) available for bromopyruvate and lonidamine

ArticleYear
The Typical Metabolic Modifiers Conferring Improvement in Cancer Resistance.
    Current medicinal chemistry, 2017, Nov-17, Volume: 24, Issue:34

    Topics: Antineoplastic Agents; Drug Design; Drug Resistance, Neoplasm; Fatty Acids; Humans; Indazoles; Metabolic Engineering; Neoplasms; Oxidative Phosphorylation; Pyruvates

2017

Other Studies

3 other study(ies) available for bromopyruvate and lonidamine

ArticleYear
The energy blockers 3-bromopyruvate and lonidamine: effects on bioenergetics of brain mitochondria.
    Journal of bioenergetics and biomembranes, 2014, Volume: 46, Issue:5

    Topics: Animals; Antineoplastic Agents; Brain; Energy Metabolism; Enzyme Inhibitors; Indazoles; Mitochondria; Oxygen Consumption; Pyruvates; Rats

2014
Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays.
    BMC research notes, 2015, Feb-20, Volume: 8

    Topics: Artifacts; Biological Assay; Cell Count; Cell Line, Tumor; Cell Survival; Deoxyglucose; Glycolysis; Humans; Indazoles; Neutral Red; Observer Variation; Oxazines; Oxidation-Reduction; Pyruvates; Reproducibility of Results; Rhodamines; Sensitivity and Specificity; Staining and Labeling; Tetrazolium Salts; Thiazoles; Xanthenes

2015
The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routes.
    Scientific reports, 2015, Sep-21, Volume: 5

    Topics: Apoptosis; Autophagy; Cell Line, Tumor; Energy Metabolism; Enzyme Inhibitors; Glioblastoma; Humans; Indazoles; Mitochondria; Pyruvates; Tumor Suppressor Protein p53

2015